- Home
- Software
- usa massachusetts
- clinical validation
Refine by
Clinical Validation Software In Usa Massachusetts
6 software items found
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
We are a regulated Software as a Medical Device (SaMD)-focused biotechnology company that develops our applications as medical treatments in accordance with all relevant FDA, ISO and IEC ...
by:Cytel based inWaltham, MASSACHUSETTS (USA)
As the character of the pharmaceutical industry changes, the need to create innovative clinical trials that de-risk uncertainty and optimize statistical design brings several advantages. The rise in the number of such adaptations also increases the ability for statistical design to be tailored to the needs of a specific trial, thereby keeping patients safe and increasing the speed of new ...
by:PathAI, Inc. based inBoston, MASSACHUSETTS (USA)
AISightTM is a web-based digital pathology slide viewing platform that enables the management and analysis of whole slide ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Identifying patterns of genomic scarring in ovarian cancer samples. Accurate identification and reporting of Homologous Recombination Deficiency (HRD) status are critical for better patient management. SOPHiA DDM Dx HRD Solution is a CE-marked in vitro diagnostic (IVD) application leveraging low-pass Whole Genome Sequencing (WGS) and a proprietary deep-learning algorithm. Powered by the advanced ...
by:Beacon Biosignals, Inc. based inBoston, MASSACHUSETTS (USA)
Beacon provides a scalable EEG analytics platform aimed at accelerating and de-risking therapeutics in neurology, psychiatry, and sleep medicine. Powered by a combination of unique data assets and machine learning algorithms, our platform identifies and standardizes neurobiomarkers to increase the probability of success at each stage of drug ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of novel ...